Strategic partnerships
Bring complementary scientific expertise, technology or development capabilities. Let’s define where working together creates value.
PARTNER WITH NUMEN
Bring the question. Build the next application.
Work with NUMEN on treatment-response questions that matter to your programme. Our starting point combines working models, scientific expertise and proprietary development.
WHO WE BUILD FOR
Built for teams developing the next therapies.
NUMEN develops applications for translational medicine and clinical development teams investigating individual treatment response.
Translational medicine
Investigate which information merits further study for a treatment-response question.
Clinical development
Evaluate how a response model could inform the next research or development decision.
Scientific collaborators
Connect relevant expertise to a shared question and a clear research scope.
Our initial research focus is psychedelic therapies.
THE FIRST PARTNER ENGAGEMENT
The Biomarker Research Package.
A focused research engagement around one treatment-response question. We agree the decision, scope and scientific output before the work begins.
Define the question
Identify the response question and the decision a useful answer would support.
Agree the scope
Set the research work, evaluation approach, responsibilities and deliverables.
Review the result
Bring findings, uncertainty and the next evaluation step into one interpretable report.
BUILT FOR REPEAT USE
Research opens the door. Reuse builds the business.
Our commercial path starts with defined research work and extends towards repeat use and licences for specific tools and models.
Start with a project
Address one focused question and agree a useful scientific output.
Extend the application
Reuse suitable models, analytical tools and infrastructure in further work.
Develop licensed products
Build towards repeatable access to defined applications as they mature.
One platform. More than one project.
OTHER WAYS TO CONNECT
Different contributions. A shared direction.
Investors and research supporters
Discuss the company behind the platform and the research that moves it forward. We welcome a long-term perspective on NUMEN’s development.
START HERE
Start with the question that matters to you.
Tell us about your organisation, the decision you are working towards and the contribution you have in mind. We will agree the next step together.